COVID-19 Testing Market Update, 2022
This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues.
At the time of publication, there is a slight decrease in cases which might suggest a decrease in COVID-19 testing revenues, but we’ve been through this before. Predicting COVID-19 is not easy. For the past two years, the disease has confounded prediction. There are at least two schools of thought about 2022. One is that COVID, as a result of the highly contagious Omicron and Delta variants, exposed enough of the population to have antibodies, and this along with strong vaccination rates and boostering, makes COVID-19 a still present but waning disease. Even in this optimistic scenario, testing will be at high volume and remains necessary throughout 2022, but there would be a decline in revenues.
A more pessimistic disease scenario would be that there are other variants that prove to be contagious, and vaccines do not provide enough long term protection and the population isn't boostering at high levels. This would represent another wave like that seen during Q4 2021 and might suggest that such waves will be with us for some time. The second scenario obviously would create COVID-19 testing revenues and volumes higher than 2021.
COVID-19 Testing Market Update, 2022 covers these topics, trends, and predictions, in addition to other essential market analysis.
- Executive Summary
- COVID-19 Testing Market Demand and Growth
- Growth Outlook
- Country Distribution
- Test Innovations and Approvals
- Table Recent COVID-19 Test Approvals and Innovations
- Trends and Developments
- Antigen and Molecular Product Developments
- Antigen
- Molecular
- Other Developments
- COVID-19 Testing Expands Multiplex Testing
- COVID-19 Drives Molecular Point of Care Growth
- AI Mines CT, Lab Results to Predict COVID-19 Severity
- Long COVID Can Be Predicted Early On
- Spectroscopy Employed in COVID-19
- Antigen and Molecular Product Developments
- Market Analysis COVID Testing
- Market Analysis: Molecular, Antigen, Antibody and Rapid Tests
- Table COVID-19 Product Sales by Type — Immunoassay, Molecular, Rapid [at home, professional POC], 2021 ($ millions)
- COVID-19 Test Market Share
- COVID-19 Test Market by Country
- Table COVID-19 Market by Country (India, China, UK, Germany, Spain, Italy, France, Mexico US, Canada, Japan, Africa / Middle East, Rest of World)
- Market Analysis: Molecular, Antigen, Antibody and Rapid Tests
- Top IVD Market Participants
- Abbott Laboratories
- Table Abbott Corporate Summary
- Table COVID-19 Test Sales, Abbott Laboratories
- Becton Dickinson
- Table Becton Dickinson Corporate Summary
- bioMérieux SA
- Table bioMérieux Corporate Summary
- Danaher Corporation
- Table Danaher Corporation Summary
- Recent Results
- Hologic, Inc.
- Table Hologic Corporate Summary
- Recent Results
- Qiagen
- Table Qiagen Corporate Summary
- Recent Results
- Quidel Corporation
- Table Quidel Corporate Summary
- Recent Results
- Roche Diagnostics
- Table Roche Diagnostic Corporate Summary
- Recent Results
- Siemens Healthineers
- Table Siemens Healthineers Corporate Summary
- Recent Results
- Thermo Fisher Scientific
- Table Thermo Fisher Scientific Corporate Summary
- Recent Results
- COVID-19 Test Providers
- Table Test Companies with an EUA-Issued COVID-19 Test (Company, Location, Test Product, Date EUA)
- Abbott Laboratories
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook